Recurrent and fatal diarrhea caused by Cystoisospora belli in a man with HIV infection

被引:0
作者
Petri, Francesco [1 ]
Angeli, Elena [1 ,6 ]
Tedesco, Michela [2 ]
Maconi, Giovanni [3 ]
Pellegrinelli, Alessandro [4 ]
Grande, Romualdo [5 ]
Rizzardini, Giuliano [1 ]
机构
[1] Luigi Sacco Univ Hosp, Infect Dis Dept, Milan, Italy
[2] Luigi Sacco Univ Hosp, Nephrol Dept, Milan, Italy
[3] Luigi Sacco Univ Hosp, Dept Biochem & Clin Sci, Gastroenterol Unit, Milan, Italy
[4] Luigi Sacco Univ Hosp, Pathol Unit, Milan, Italy
[5] Luigi Sacco Univ Hosp, Clin Microbiol Virol & Bioemergency, Milan, Italy
[6] Luigi Sacco Hosp, Div Infect Dis 1, Milan, Italy
来源
HIV & AIDS REVIEW | 2024年 / 23卷 / 01期
关键词
HIV; Cystoisospora belli; opportunistic infections; immunodepression; ISOSPORA-BELLI; PROPHYLAXIS; THERAPY;
D O I
10.5114/hivar.2024.135848
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Cystoisospora belli causes intestinal infection in immunocompromised hosts, including human immunodeficiency viruses (HIV)-positive patients, especially from tropical and sub-tropical areas, with watery and recurrent diarrhea, leading in advanced cases to malabsorption and death. Microbiological diagnosis is limited by intermittent or low shedding of oocysts in stool; therefore, endoscopy may be necessary to identify the pathogen in histological samples. Trimethoprim-sulfamethoxazole (TMP-SMX) represents the treatment of choice, and alternative agents are used in recurrences, but limited efficacy is described. Here, we present recently observed case of severe and fatal infection due to C. belli in a HIV-positive 40-year-old man from Brazil, revealing several limitations in diagnosis and therapy, which need to be investigated further. In particular, it is still not clear how the infection persisted over time leading to malabsorption, kidney injury, and subsequent death, even if a reasonable immune reconstitution was demonstrated. Additionally, we investigated what mechanisms might cause, whether failure of recovery of the immune response specifically to C. belli, drug malabsorption, resistance to TMP-SMX, sequestration into lymphoid tissue, or co-presence of visceral untreated Kaposi sarcoma. Also, the appropriate dosage and way of administration of the best therapeutic regimen were examined, since there is a lack of literature on these issues. Globalization and wider use of immunosuppressive therapies underline the importance of maintaining adequate awareness, also in HIV-negative and non-immigrant populations.
引用
收藏
页码:104 / 106
页数:3
相关论文
共 8 条
[1]   Failure to Eradicate Isospora belli Diarrhoea Despite Immune Reconstitution in Adults with HIV - A Case Series [J].
Boyles, Tom H. ;
Black, John ;
Meintjes, Graeme ;
Mendelson, Marc .
PLOS ONE, 2012, 7 (08)
[2]   CLINICAL MANIFESTATIONS AND THERAPY OF ISOSPORA-BELLI INFECTION IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
DEHOVITZ, JA ;
PAPE, JW ;
BONCY, M ;
JOHNSON, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (02) :87-90
[3]   Cystoisospora belli infections in humans: the past 100 years [J].
Dubey, J. P. ;
Almeria, S. .
PARASITOLOGY, 2019, 146 (12) :1490-1527
[4]   Isosporiasis in patients with HIV infection in the highly active antiretroviral therapy era in France [J].
Lagrange-Xelot, M. ;
Porcher, R. ;
Sarfati, C. ;
de Castro, N. ;
Carel, O. ;
Magnier, J-D ;
Delcey, V. ;
Molina, J-M .
HIV MEDICINE, 2008, 9 (02) :126-130
[5]  
National Institutes of Health, 2021, Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV Guidance for COVID-19 and People with HIV, pA1
[6]   TREATMENT AND PROPHYLAXIS OF ISOSPORA-BELLI INFECTION IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
PAPE, JW ;
VERDIER, RI ;
JOHNSON, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (16) :1044-1047
[7]  
Silva-Díaz H, 2017, REV CHIL INFECTOL, V34, P347, DOI 10.4067/s0716-10182017000400347
[8]   Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients -: A randomized, controlled trial [J].
Verdier, RI ;
Fitzgerald, DW ;
Johnson, WD ;
Pape, JW .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (11) :885-888